Pharmacy Search
Vertice Login
Menu
close

Medmonitor

An up-to-date timeline of U.S. Food and Drug Administration (FDA) approvals that could potentially impact workers' compensation. These include new drug and indication approvals, new dosages or formulations of existing products, and generics introduced to the market. Click through the interactive timeline below, or select the comprehensive list view.
← Back to Medmonitor

Medication Type: Opioid

Dilaudid (hydromorphone hydrochloride) injection

Approval Date: Feb 2024

Note: First-Time Generic

Indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate

Medication Name

Approval Date

Category

Description

Dilaudid (hydromorphone hydrochloride) injection

Feb 2024

Indicated for the management of pain severe enough to require an opioid analgesic and for which alternate treatments are inadequate

Note: First-Time Generic
lockenvelopephone-handsetmagnifiermenucross-circle